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Abstract  
 
Previously, we reported that prostanoid TP receptor mediates the inhibition of 
electrically evoked noradrenaline release from gastric sympathetic nerves in rats. 
Prostanoid TP receptor has been shown to activate phospholipase C (PLC), which 
catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate to inositol 
1,4,5-triphosphate (IP3) and diacylglycerol; IP3 triggers the release of Ca
2+
 from 
intracellular stores and diacylglycerol activates protein kinase C. In the present study, 
therefore, we examined whether these PLC-mediated mechanisms are involved in the 
TP receptor-mediated inhibition of gastric noradrenaline release using an isolated, 
vascularly perfused rat stomach. U-46619 (9,11-dideoxy-9α,11α-methanoepoxy PGF2α) 
(a prostanoid TP receptor agonist)-induced inhibition of noradrenaline release from the 
stomach was reduced by U-73122 
[1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]-amino]hexyl]-1H-pyrrole-2,5-dine] 
(a PLC inhibitor) and ET-18-OCH3 (1-O-octadecyl-2-O-methyl-sn-glycero- 
3-phosphorylcholine) (a phosphatidylinositol-specific PLC inhibitor), respectively. 
2-APB (2-aminoethyldiphenyl borate) (a putative IP3 receptor antagonist) also abolished 
the U-46619-induced inhibition of noradrenaline release, but Ro 31-8220 
[2-{1-[3-(amidinothio)propyl]-1H-indol-3-yl}-3-(1-methylindol-3-yl)-maleimide] (a 
protein kinase C inhibitor) had no effect. Furthermore, a small dose of 
tetraethylammonium and charybdotoxin [blockers of BK-type Ca
2+
-activated K
+
 
channel] abolished the U-46619-induced inhibition, but apamin (a blocker of SK-type 
Ca
2+
-activated K
+ 
channel) had no effect. These results suggest that BK type 
Ca
2+
-activated K
+
 channels are involved in prostanoid TP receptor-mediated inhibition 
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of electrically evoked noradrenaline release from the gastric sympathetic nerve 
terminals in rats.  
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1. Introduction  
 
Cytosolic Ca
2+ 
plays an important role in regulating a variety of neuronal processes 
such as regulation of cell membrane excitability, exocytosis of neurotransmitters, cell 
growth and gene expression (Berridge, 1998). Increases in cytosolic Ca
2+ 
can result 
from Ca
2+ 
influx through the plasma membrane and Ca
2+ 
release from an intracellular 
Ca
2+
 store through intracellular Ca
2+ 
release channels. Two types of intracellular Ca
2+ 
release channels, ryanodine receptors and inositol 1,4,5-triphosphate (IP3) receptors, 
exist on the neuronal endoplasmic reticulum, which is a specialized Ca
2+
 storing 
organelle and makes a continuous network distributed throughout neurons including 
synaptic terminals (Verkhratsky, 2005). Ca
2+ 
release via ryanodine receptors, termed 
Ca
2+
-induced Ca
2+
 release, is activated by an increase in intracellular Ca
2+
 from Ca
2+
 
influx through the plasma membrane voltage- or ligand-gated channels (Verkhratsky 
and Shmigol, 1996), while Ca
2+ 
release through IP3 receptors, termed IP3-induced Ca
2+
 
release, is activated by an increase in intracellular IP3, which is generated through 
cleavage of phosphatidylinositide lipids by phospholipase C (PLC) coupled to 
cell-surface receptors (Berridge, 1993).  
Both types of intracellular Ca
2+
 release channels are heterogeneously distributed on 
neuronal cell bodies and synaptic terminals (Llano et al., 2000; Bouchard et al., 2003) 
and their activation triggers cytoplasmic Ca
2+
 signals to evoke neurotransmitter release 
in the central and peripheral neurons (Smith and Cunnane, 1996; Kubota et al., 2005: 
Mathew and Hablitz, 2008). In several types of neurons, however, elevation of 
intracellular Ca
2+ 
has been shown to
 
activate Ca
2+
-activated K
+
 channels, thereby 
producing a long-lasting after-hyperpolarization of an action potential to reduce 
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neurotransmitter release from synaptic terminals (Cassell and McLachlan, 1987; Kawai 
and Watanabe, 1989; Marrion and Tavalin, 1998). The IP3-evoked activation of 
Ca
2+
-activated K
+
 channels plays a role in regulating the excitability of rat midbrain 
dopamine neurons (Morikawa et al., 2000). Furthermore, ryanodine receptors have been 
shown to form a functional triad with Ca
2+
-activated K
+
 channels and voltage-gated 
Ca
2+ 
channels located on the cell membrane, thereby directly shaping the spike 
repolarization of an action potential in bullfrog sympathetic neurons (Akita and Kuba, 
2000).  
Prostanoids have been shown to modulate noradrenaline release from central and 
peripheral noradrenergic nerves (Starke et al., 1989; Malik and Sehic, 1990). In a 
previous study, we reported that prostanoid TP receptors located on the sympathetic 
nerve terminals mediate the inhibition of electrically evoked noradrenaline release from 
the rat stomach (Yokotani et al., 2003). TP receptors have been shown to couple with 
PLC-mediated Ca
2+
 signaling in the guinea pig airway smooth muscle (Shiraki et al., 
2009), rat pulmonary artery (McKenzie et al., 2009) and cultured rat myenteric neurons 
(Rehn and Diener, 2006). Therefore, in the present study, we tried to clarify the 
mechanisms involved in prostanoid TP receptor-mediated inhibition of noradrenaline 
release from the rat stomach with regard to PLC-mediated Ca
2+
 signaling.  
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2. Materials and methods  
 
2.1. Perfusion experiments 
  
The present experiments were conducted in compliance with the guiding principles 
for care and use of laboratory animals approved by Kochi University. All efforts were 
made to minimize animal suffering and the number of animals used.  
Male Wistar rats (Japan SLC, Inc., Hamamatsu, Japan) weighing about 400 g were 
fasted overnight before experiments. The isolated, vascularly perfused stomach 
preparations were made as described previously (Yokotani et al., 1992; Nakamura et al., 
2003). Briefly, under urethane anesthesia, the abdomen was opened with a midline 
incision. After ligation of the abdominal aorta just above the branching of the celiac 
artery, the cannula was inserted into the celiac artery via an incision placed on the aorta 
and modified Krebs-Ringer solution (pH 7.4) bubbled with a mixture of 95% O2 and 
5% CO2 was perfused with a constant flow rate of 2.5 ml per min. Modified 
Krebs-Ringer solution was composed of 117.5 mM NaCl, 4.7 mM KCl, 2.4 mM CaCl
2
, 
1.1 mM MgCl
2
, 1.1 mM NaH
2
 PO
4
, 25 mM NaHCO
3
, 11.1 mM glucose, 0.05% bovine 
serum albumin, 3 μM indomethacin, 10 μM pargyline and 1 μM phentolamine. A tube 
was inserted into the lumen of the stomach via a pylorus ring to drain the contents of 
the stomach throughout the experiment. The esophagus, duodenum, spleen and pancreas 
were dissected after ligation of the vessels, and the vascularly perfused stomach was 
kept in a chamber prewarmed at 37°C. Each 2-min effluent from the portal vein was 
collected in chilled tubes containing 0.5 ml of 4 M perchloric acid, 1 ng of 
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3,4-dihydroxybenzylamine (DHBA) as an internal standard, and 50 μl of 2% sodium 
pyrosulfite solution.  
After an equilibration period of 60 min, perfusion medium was changed to the new 
medium containing none or one blocking reagent such as PLC inhibitors, a protein 
kinase C (PKC) inhibitor, an inositol 1,4,5-triphosphate (IP3) receptor antagonist or K
+ 
channel blocker. The first electrical stimulation [consisting of square-wave pulses at 1.0 
Hz, 2 ms duration, 15 mA (a supramaximal intensity) for 1 min] was applied to 
periarterial nerves around the left gastric artery, which contain the postganglionic 
sympathetic nerves, with bipolar electrodes, at 14 min after the start of new medium. 
The second stimulation was carried out 26 min after the first stimulation. Perfusion of 
U-46619 (a prostanoid TP receptor agonist) was started at 14 min before the second 
stimulation and continued until the end of experiment with or without one blocking 
reagent described above. 
 
2.2. Noradrenaline assay in the medium and the stomach 
 
At the end of each experiment, the stomach was homogenized in 20 ml of 0.4 M 
perchloric acid containing 18.6 mg of disodium EDTA dihydrate, 200 μl of 2% sodium 
pyrosulfite solution and 500 ng of DHBA as an internal standard. The homogenate was 
centrifuged for 10 min at 14,000 g at 4°C. The supernatant was analyzed to determine 
the tissue level of noradrenaline. 
Catecholamines in the effluent and the supernatant of tissue homogenate were 
extracted by the method of Anton and Sayre (1962) with a slight modification, and were 
assayed electrochemically with high-performance liquid chromatography (HPLC) 
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(Yokotani et al., 1992; Nakamura et al., 2003). Specifically, 2 ml of effluent or an 
aliquot (0.1 ml) of supernatant was transferred to a centrifuge tube containing 30 mg of 
activated alumina and 3 ml of 1.5 M Tris Buffer (pH 8.6) containing 0.1 M disodium 
EDTA dihydrate, then the preparations were shaken for 10 min. The supernatant was 
discarded and the alumina was washed three times with chilled twice-deionized water. 
Then, noradrenaline adsorbed onto the alumina was eluted with 500 µl of 4% acetic 
acid containing 0.1 mM disodium EDTA dihydrate. The recovery of catecholamines by 
these procedures was about 85%. 
The HPLC-electrochemical detection system consisted of a pump (PU-980: JASCO, 
Tokyo, Japan), a sample injector (AS-2050: JASCO) and an electrochemical detector 
(ECD-300: Eicom, Kyoto, Japan) equipped with a graphite electrode. Analytical 
conditions were as follows: detector, +450 mV potential against a Ag/AgCl reference 
electrode; column, Cosmosil 5C18-PAQ, 4.6 x 150 mm (Nacalai Tesque, Kyoto, Japan); 
column temperature, 35.0°C; mobile phase, 0.1 M NaH2PO4-Na2HPO4 buffer (pH 6.0) 
containing 50 mg/l disodium EDTA dihydrate, 3.45 g/l sodium 1-octanesulfonate 
(Nacalai Tesque) and 18% methanol at a flow rate of 0.5 ml/min. The amount of 
noradrenaline in each sample was calculated using the peak height ratio relative to that 
of DHBA. This assay could accurately determine 2 pg of noradrenaline. 
 
2.3. Evaluation and statistical analysis 
 
Released noradrenaline from the stomach is expressed as percentage of its tissue 
content per 2 min. Basal release is the value just before the electrical stimulation. The 
amounts of released noradrenaline above the basal during 12 min after the first and 
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second stimulation are expressed as S1 and S2 , respectively. The effect of prostanoid TP 
receptor agonist (U-46619) is expressed as the ratio of S2 to S1 determined in the 
absence (the control) or presence of this reagent during the second stimulation. All 
values are expressed as the means±S.E.M. 
Data were analyzed by repeated-measures analysis of variance (ANOVA), followed 
by post-hoc analysis with the Bonferroni method for comparing the control to all other 
means (Fig. 1B). When only two means were compared, the data were analyzed by an 
unpaired Student’s t-test or Welch’s t-test (Figs. 1A, 2-4). P values of less than 0.05 
were taken to indicate statistical significance.  
 
2.4. Compounds  
 
The following drugs were used: 2-aminoethoxydiphenyl borate (2-APB), 
indomethacin, pargyline hydrochloride, phentolamine hydrochloride, 
tetraethylammonium (TEA) chloride (Sigma-Aldrich Fine Chemicals, St. Louis, MO, 
U.S.A.); apamin, charybdotoxin (Peptide Institute Inc. Osaka, Japan); 
9,11-dideoxy-9α,11α-methanoepoxy PGF2α (U-46619) (Cayman Chemical Co., Ann 
Arbor, MI, U.S.A.); 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine 
(ET-18-OCH3), 
2-{1-[3-(amidinothio)propyl]-1H-indol-3-yl}-3-(1-methylindol-3-yl)-maleimide (Ro 
31-8220), 1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]- 
amino]hexyl]-1H-pyrrole-2,5-dine] (U-73122) (Biomol Research Lab., Plymouth 
Meeting, PA, U.S.A.); 3,4-dihydroxybenzylamine (DHBA) (Alfa Aesar, Ward Hill, MA, 
U.S.A.); activated alumina (Wako Pure Chemical Industries, Ltd.). All other reagents 
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were of the highest grade available (Nacalai Tesque). Indomethacin, U-46619 and 
ET-18-OCH3 were dissolved in 100% ethanol, then the final concentration of ethanol in 
the perfusion medium was max. 0.09%. U-73122 and 2-APB were dissolved in 100% 
N,N-dimethylformamide (DMF) and the final concentration of DMF was max. 0.1%. In 
all controls, ethanol and/or DMF were added at the same concentration(s) as in the 
corresponding experiments. 
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3. Results  
 
3.1. Effect of U-46619 on the electrically evoked release of noradrenaline from the 
isolated rat stomach 
 
In the whole cohort of rats used in the present study, the amount of noradrenaline 
remaining in the stomach at the end of each experiment was 635.7±10.0 ng (n=107).  
The basal release of noradrenaline before the first electrical stimulation of gastric 
sympathetic nerves was 0.047±0.002% of its tissue content per 2 min (n=18) (Fig. 1A). 
The first stimulation at 1.0 Hz for 1 min evoked an increase of noradrenaline release 
and this increase rapidly declined toward their basal level (S1=0.353±0.032% of its 
tissue content per 12 min, n=18). In the control experiment, the second electrical 
stimulation evoked a consistent and reproducible noradrenaline release (S2/S1 ratio= 
0.986±0.011, n=6) (Fig. 1, A and B). 
After the first stimulation, the perfusion medium was changed to the next one 
containing U-46619 (an agonist of the prostanoid TP receptors) (0.1 and 0.3 μM). 
U-46619 (0.1 and 0.3 μM) significantly inhibited the evoked noradrenaline release to 
the same extent [S2/S1 ratio was 0.635±0.069 for 0.1 μM (n=6) and 0.638±0.077 for 0.3 
μM (n=6), respectively] (Fig. 1, A and B), as shown in a previous paper in which 
U-46619 (0.01, 0.1 and 0.3μM) inhibited the evoked noradrenaline release from the rat 
stomach with a maximal inhibition at 0.1 μM (Yokotani et al., 2003). Thus, 0.1 M of 
U-46619 was used in the following experiments. 
 
3.2. Effects of U-73122 and ET-18-OCH3 on the U-46619-induced inhibition of the 
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evoked noradrenaline release from the isolated rat stomach 
 
U-73122 (3 μM) (an inhibitor of PLC) or ET-18-OCH3 (3 μM) (an inhibitor of 
phosphatidylinositol-specific PLC) was added throughout the experiments. 
ET-18-OCH3 (3 μM), but not U-73122 (3 μM), slightly but significantly (p<0.05; 
compared to that of non-treated group in Fig. 1) elevated the basal noradrenaline release 
before the first stimulation [0.057±0.004% of its tissue content per 2 min for U-73122 
(3 μM)-treated group (n=10) and 0.076±0.004% for ET-18-OCH3 (3 μM)-treated group 
(n=9), respectively].  
U-73122 (3 μM) and ET-18-OCH3 (3 μM) had no effect on the first 
stimulation-induced increase of noradrenaline release from the stomach 
[S1=0.314±0.030% of its tissue content per 12 min for U-73122 (3 μM)-treated group 
(n=10), and 0.303±0.018% for ET-18-OCH3 (3 μM)-treated group (n=9), respectively]. 
Under the presence of these reagents, the second stimulation of the gastric sympathetic 
nerves evoked a consistent and reproducible noradrenaline release [S2/S1 ratios were 
0.980±0.017 for U-73122 (3 μM)-treated group (n=5) and 1.096±0.086 for ET-18-OCH3 
(3 μM)-treated group (n=5), respectively] (Fig. 2, A and B). 
In the presence of U-73122 (3 μM) or ET-18-OCH3 (3 μM), the U-46619 (0.1 
μM)-induced inhibition of the evoked noradrenaline release disappeared [S2/S1 ratios 
were 0.903±0.033 for U-73122 (3 μM)-treated group (n=5) and 1.025±0.037 for 
ET-18-OCH3 (3 μM)-treated group (n=4), respectively] (Fig. 2, A and B).  
 
3.3. Effects of Ro 31-8220 and 2-APB on the U-46619-induced inhibition of the evoked 
noradrenaline release from the isolated rat stomach 
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Ro 31-8220 (1 or 3 μM) (an inhibitor of PKC) or 2-APB (75 μM) (a putative 
antagonist of IP3 receptor) was added throughout the experiments. Ro 31-8220 (1 μM) 
and 2-APB (75 μM), but not Ro 31-8220 (3 μM), slightly but significantly (p<0.05; 
compared to that of non-treated group in Fig. 1) elevated the basal noradrenaline release 
before the first stimulation [0.077±0.004% of its tissue content per 2 min for Ro 
31-8220 (1 μM)-treated group (n=13), 0.066±0.006% for Ro 31-8220 (3 μM)-treated 
group (n=8), and 0.105±0.010% for 2-APB (75 μM)-treated group (n=10), 
respectively].  
Ro 31-8220 (1 and 3 μM) and 2-APB (75 μM) had no effect on the first 
stimulation-induced increase of noradrenaline release from the stomach 
[S1=0.344±0.016% of its tissue content per 12 min for Ro 31-8220 (1 μM)-treated group 
(n=13), and 0.311±0.025% for Ro 31-8220 (3 μM)-treated group (n=8), and 
0.316±0.014% for 2-APB (75 μM)-treated group (n=10), respectively]. Under the 
presence of these reagents, the second stimulation evoked a consistent and reproducible 
noradrenaline release (Fig. 3, A and B) [S2/S1 ratio= 0.988±0.041 for Ro 31-8220 (1 
μM)-treated group (n=7), 0.880±0.028 for Ro 31-8220 (3 μM)-treated group (n=4), and 
0.935±0.043 for 2-APB (75 μM)-treated group (n=6), respectively]. 
In the presence of Ro 31-8220 (1 and 3 μM), U-46619 (0.1 μM) still effectively 
inhibited the evoked noradrenaline release from the stomach (Fig. 3A) [S2/S1 ratio= 
0.708±0.067 for Ro 31-8220 (1 μM)-treated group (n=6), 0.702±0.033 for Ro 31-8220 
(3 μM)-treated group (n=4), respectively]. However, the U-46619–induced inhibition 
was abolished by 2-APB (75 μM) (Fig. 3B) [S2/S1 ratio= 0.943±0.057 for 2-APB (75 
μM)-treated group (n=4)].   
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3.4. Effects of TEA, charybdotoxin and apamin on the U-46619-induced inhibition of 
the evoked noradrenaline release from the isolated rat stomach 
 
TEA (1.0 mM), charybdotoxin (0.01 or 0.03 μM) or apamin (0.3 μM) was added 
throughout the experiments. TEA (1.0 mM) and charybdotoxin (0.01 μM), but not 
charybdotoxin (0.03 μM) and apamin (0.3 μM), slightly but significantly (p<0.05; 
compared to that of non-treated group in Fig. 1) elevated the basal noradrenaline release 
before the first stimulation [0.066±0.004% of its tissue content per 2 min for TEA (1.0 
mM)-treated group (n=12), 0.063±0.005% for charybdotoxin (0.01 μM)-treated group 
(n=10), 0.058±0.004% for charybdotoxin (0.03 μM)-treated group (n=9), and 
0.052±0.003% for apamin (0.3 μM)-treated group (n=8), respectively].  
TEA (1.0 mM) significantly (p<0.05; compared to that of non-treated group in Fig. 
1) elevated the first stimulation-induced increase of noradrenaline release from the 
stomach [S1=0.681±0.052% of its tissue content per 12 min for TEA (1.0 mM)-treated 
group (n=12)], although charybdotoxin (0.01 or 0.03 μM) and apamin (0.3 μM) had no 
effect on the first stimulation-induced increase of noradrenaline release 
[S1=0.448±0.043% for charybdotoxin (0.01 μM)-treated group (n=10), 0.458±0.022% 
for charybdotoxin (0.03 μM)-treated group (n=9), and 0.291±0.049% for apamin (0.3 
μM)-treated group (n=8), respectively]. Under the presence of these reagents, the 
second stimulation evoked a consistent and reproducible noradrenaline release (Fig. 4, 
A, B and C) [S2/S1 ratios were 1.082±0.026 for TEA (1.0 mM)-treated group (n=8), 
1.034±0.036 for charybdotoxin (0.01 μM)-treated group (n=6), 0.971±0.101 for 
charybdotoxin (0.03 μM)-treated group (n=4), and 0.988±0.026 for apamin (0.3 
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μM)-treated group (n=4), respectively].   
In the presence of TEA (1.0 mM), U-46619 (0.1 μM)–induced inhibition of the 
evoked noradrenaline release from the stomach disappeared (Fig. 4A) [S2/S1 
ratio=1.138±0.139, n=4]. Charybdotoxin (0.01 μM) had no effect on the 
U-46619-induced inhibition of the evoked noradrenaline release, however at 0.03 μM 
the peptide significantly (p<0.05) attenuated the U-46619-induced inhibition of the 
noradrenaline release (Fig. 4B) [S2/S1 ratios were 0.502±0.059 for charybdotoxin (0.01 
μM)-treated group (n=4) and 0.833±0.039 for charybdotoxin (0.03 μM)-treated group 
(n=5), respectively]. On the other hand, a large dose of apamin (0.3 μM) had no effect 
on the U-46619-induced inhibitory responses (Fig. 4C) (S2/S1 ratio was 0.783±0.037, 
n=4).  
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4. Discussion 
 
Stimulation of prostanoid TP receptors has been shown to cause diverse biological 
effects via activation of several effectors such as PLC, adenylyl cyclase and nucleotide 
exchange factor of Rho (Huang et al., 2004; Nakahata, 2008). In the present study, 
U-46619, a prostanoid TP receptor agonist, effectively attenuated the electrically evoked 
noradrenaline release from the isolated rat stomach, as show in a previous paper 
(Yokotani et al., 2003). Thus, we attempted to clarify the mechanism involved in the 
prostanoid TP receptor-mediated inhibition of gastric noradrenaline release with regard 
to PLC. U-73122 has been shown to be a selective inhibitor of PLC in human platelets 
and polymorphonuclear neutrophils (Bleasdale et al., 1990; Smith et al., 1990) and to 
antagonize the hyperalgesia evoked by histamine H1 receptor agonist 
[2-(3-trifluoromethylphenyl)histamine]-induced activation of brain PLC in mice 
(Galeotti et al., 2004). In the present experiment, U-73122 effectively attenuated the 
prostanoid TP receptor-mediated inhibitory response, suggesting the involvement of 
PLC in the prostanoid TP receptor-mediated inhibition of noradrenaline release from the 
rat stomach. 
To date, PLC has pharmacologically been divided into two types, 
phosphatidylinositol-specific PLC and phosphatidylcholine-specific PLC. The former 
hydrolyzes phosphatidylinositol phosphate(s) while the latter hydrolyzes 
phosphatidylcholine, thereby both generating diacylglycerol. The source of early 
production of diacylglycerol has been shown to be exclusively mediated by 
phosphatidylinositol-specific PLC, while phosphatidylcholine is the source of sustained 
production of diacylglycerol by phosphatidylcholine-specific PLC (Exton, 1994; 
Rebecchi and Pentyala, 2000). Then, we examined which PLC is involved in the 
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prostanoid TP receptor-mediated inhibition of gastric noradrenaline release using 
ET-18-OCH3, an inhibitor of phosphatidylinositol-specific PLC (Powis et al., 1992). In 
the present experiment, ET-18-OCH3 effectively attenuated the prostanoid TP 
receptor-mediated inhibitory response, suggesting the involvement of the neuronal 
phosphatidylinositol-specific PLC in the prostanoid TP receptor-mediated inhibition of 
gastric noradrenaline release in rats. 
Phosphatidylinositol-specific PLC catalyzes the hydrolysis of phosphatidylinositol 
4,5-bisiphosphate to produce diacylglycerol in addition to IP3. Diacylglycerol functions 
as an intracellular second messenger to activate PKC (Nishizuka, 1992). PKC-induced 
inhibition of voltage-sensitive Ca
2+
 channels has been shown to reduce catecholamine 
secretion from adrenal chromaffin cells (Sena et al., 1995). Ro 31-8220, a selective 
inhibitor of PKC (Dieter and Fitzke, 1991), effectively attenuated the PKC-dependent 
[
3
H]-dopamine release from rat striatal synaptosomes at 1 μM (Soliakov and Wonnacott, 
2001) and the phorbol ester-induced activation of PKC in the rat calyx of Held synapse 
at 3 μM (Korogod et al., 2007; Lou et al., 2008). In the present experiment, Ro 31-8220 
even at 3 μM had no effect on the prostanoid TP receptor-mediated response, suggesting 
that the neuronal PKC is not involved in the prostanoid TP receptor-mediated inhibition 
of gastric noradrenaline release in rats. 
IP3, the other product of phosphatidylinositol-specific PLC, is water-soluble and 
diffuses rapidly within the cytosol to interact with IP3 receptors on the endoplasmic 
reticulum in neurons, including synaptic terminals (McGraw et al., 1980; Verkhratsky, 
2005). The IP3 receptors located on the endoplasmic reticulum function as intracellular 
Ca
2+
 channels to release luminal stored Ca
2+ 
of endoplasmic reticulum and generate the 
initial Ca
2+
 signal phase (Wang and Thompson, 1995). IP3-induced Ca
2+
 release is 
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elicited by activation of PLC-coupled receptors such as metabotropic glutamate 
receptors in the rat hippocampal CA1 pyramidal neurons (Nakamura et al., 1999), 
muscarinic ACh receptors in the rat hippocampal neurons and rat cerebellar granule 
neurons (Simpson et al., 1996; Irving and Collingridge, 1998) and bradykinin receptors 
in the rat sympathetic neurons (Cruzblanca et al., 1998; Liu et al., 2007). In addition, the 
depletion of Ca
2+
 stored within the endoplasmic reticulum by IP3-induced Ca
2+
 release 
serves as a primary trigger for a message which is returned to the plasma membrane 
resulting in the activation of a “store-operated channel” (SOC) which allows the entry 
of external Ca
2+
 (Parekh and Penner, 1997). In the present experiment, we examined 
whether a rise of intracellular Ca
2+
 concentration is involved in the prostanoid TP 
receptor-mediated inhibition of gastric noradrenaline release with 2-APB, which inhibits 
both IP3 receptor and SOC at high concentrations (50-100 μM), thereby suppressing the 
elevation of the intracellular Ca
2+ 
concentration at the nerve terminal (Wu et al., 2000; 
Prakriya and Lewis, 2001; Ma et al., 2002). In the present experiment, 75 μM of 2-APB 
abolished the prostanoid TP receptor-mediated inhibitory response. The result suggests 
a possibility that IP3-induced Ca
2+
 release from the endoplasmic reticulum is involved in 
the prostanoid TP receptor-mediated inhibition of gastric noradrenaline release from the 
sympathetic nerve terminals in rats.  
IP3-induced Ca
2+
 release results in the activation of Ca
2+
-activated
 
K
+
 channels in 
neurons (Hoesch et al., 2004). The activation of K
+ 
channels negatively influences 
neuronal excitability and neurotransmitter release (Hu et al., 2001; Raffaelli et al., 2004). 
Ca
2+
-activated K
+ 
channels are classified into large-conductance Ca
2+
-activated K
+ 
channels (BK channels) and small-conductance Ca
2+
-activated K
+ 
channels (SK 
channels). In neurons, Ca
2+
-activated K
+ 
channels mediate action potential 
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repolarization and after-hyperpolarization following action potentials; the former is 
mediated by BK channel activation and the latter by SK channel activation (Storm, 
1987; Sah, 1996). BK channels are selectively inhibited by a small dose of TEA (Storm, 
1987), charybdotoxin (Gimenez-Gallego et al., 1988) and iberiotoxin (Galvez et al., 
1990), while SK channels are selectively inhibited by apamin (Blatz and Magleby, 
1986). In the present experiment, a small dose of TEA (1.0 mM) and charybdotoxin 
(0.03 μM) effectively attenuated the prostanoid TP receptor-mediated inhibition of 
gastric noradrenaline release, while apamin (0.3 μM) had no effect. These results 
suggest the involvement of Ca
2+
-activated BK channels in the prostanoid TP 
receptor-mediated inhibition of the evoked gastric noradrenaline release from the 
sympathetic nerve terminals in rats. In accordance with these results, Rehn and Diener 
(2006) also demonstrated that in cultured rat myenteric nourons, carbocyclic 
thromboxane A2, a stable thromboxane A2 derivative, elicits the elevation of neuronal 
cytosolic Ca
2+
 concentration by PLC-mediated mechanisms, thereby hyperpolarizing 
the plasma membrane via activation of BK channels. 
Using rat hippocampal or olfactory bulb slices, numerous electrophysiological 
studies have been shown an implication of postsynaptic BK channels to repolarization 
of somatodendritic action potentials, generation of fast after-hyperpolarization, spike 
broadening during repetitive firing and a close association with glutaminergic NMDA 
receptors (Shao et al., 1999; Isaacson and Murphy, 2001). Presynaptic expression of BK 
channels also suggests their pivotal role for regulating neurotransmitter release as an 
“emergency brake”, which protects against hyperactivity, particularly in pathological 
conditions such as brain ischemia and epilepsy (Hu et al., 2001; Runden-Pran et al., 
2002; Raffaelli et al., 2004). The present study demonstrates the possibility that 
 20 
presynaptic BK channels are also involved in some presynaptic receptor-mediated 
inhibition of neurotransmitter from nerve terminals.  
In conclusion, we propose that the activation of prostanoid TP receptors located on 
gastric sympathetic nerve terminals elicits IP3-induced Ca
2+
 release from the 
endoplasmic reticulum via PLC-mediated mechanisms, which leads to the activation of 
BK channels resulting in the suppression of membrane potential, thereby inhibiting the 
electrically evoked noradrenaline release from gastric sympathetic nerve terminals in 
rats.  
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Legends to figures 
 
Fig. 1. Effect of U-46619 on the electrically evoked release of noradrenaline from the 
isolated rat stomach. Periarterial nerves around the left gastric artery, which contain the 
gastric postganglionic sympathetic nerves, were electrically stimulated twice at a 
stimulus frequency of 1.0 Hz for 1 min. The first stimulation was carried out in normal 
medium and the second stimulation was carried out in medium containing U-46619 (a 
prostanoid TP receptor agonist) (0.1 or 0.3 M). (A) noradrenaline (NA) release is 
expressed as a percentage of its tissue content per 2 min. E.S., electrical stimulation of 
the gastric sympathetic nerves. Values are the means±S.E.M. *Significant difference 
(P<0.05) from the corresponding value. (B) Effects of U-46619 are expressed as the 
S2/S1 ratio. Numbers in parenthesis represent the number of experiments. *Significant 
difference (P<0.05) from the control value. 
 
Fig. 2. Effects of U-73122 and ET-18-OCH3 on the U-46619-induced inhibition of 
noradrenaline release from the isolated rat stomach. The gastric sympathetic nerves 
were electrically stimulated twice at a stimulus frequency of 1.0 Hz for 1 min. (A) 
U-73122 (an inhibitor of PLC) (3 M) or (B) ET-18-OCH3 (an inhibitor of 
phosphatidylinositol-specific PLC) (3 M) was added throughout experiments. 
U-46619 (a prostanoid TP receptor agonist) (0.1 M) was added during the second 
electrical stimulation in (A) and (B). The effect of U-46619 is expressed as the S2/S1 
ratio. The values of control and U-46619-treated experiments without PLC inhibitors in 
(A) and (B) were cited from Fig. 1B. *Significant difference (P<0.05) from the control 
value. Other conditions were the same as those in Fig. 1B.   
 31 
  
Fig. 3. Effects of Ro 31-8220 and 2-APB on the U-46619-induced inhibition of 
noradrenaline release from the isolated rat stomach. The gastric sympathetic nerves 
were electrically stimulated twice at a stimulus frequency of 1.0 Hz for 1 min. (A) Ro 
31-8220 (a PKC inhibitor) (1 or 3 M) or (B) 2-APB (a putative IP3 receptor 
antagonist) (75 M) was added throughout experiments. U-46619 (a prostanoid TP 
receptor agonist) (0.1 M) was added during the second electrical stimulation in (A) 
and (B). The effect of U-46619 is expressed as the S2/S1 ratio. The values of control and 
U-46619-treated experiments without Ro 31-8220 and 2-APB in (A) and (B) were cited 
from Fig. 1B. *Significant difference (P<0.05) from the control value. Other conditions 
were the same as those in Figs. 1 and 2.  
 
Fig. 4. Effects of TEA, charybdotoxin and apamin on the U-46619-induced inhibition of 
noradrenaline release from the isolated rat stomach. The gastric sympathetic nerves 
were electrically stimulated twice at a stimulus frequency of 1.0 Hz for 1 min. 
Tetraethylammonium (TEA) (1.0 mM) and charybdotoxin (ChTX) (0.01 or 0.03 mM) 
(selective blockers of BK type Ca
2+
-activated K
+
 channel) or apamin  (0.3 mM) (a 
selective blocker of SK type Ca
2+
-activated K
+
 channel) was added throughout 
experiments. U-46619 (a prostanoid TP receptor agonist) (0.1 mM) was added during 
the second electrical stimulation. The effects of these reagents are expressed as the S2/S1 
ratio. The values of control and U-46619-treated experiments without TEA, 
charybdotoxin and apamin in (A), (B) and (C) were cited from Fig. 1B. *Significant 
difference (P<0.05) from each control. Other conditions were the same as those in Figs. 
1-3.  
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